AlphaGrep UK’s Sabra Healthcare REIT SBRA Stock Holding History

AlphaGrep UK’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-28,939	Closed	-$565K	–	927
2026 Q2	$565K	Buy	+28,939	New	+$574K	0.17%	184

Other funds holding SBRA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Centersquare Investment Management Conshohocken, Pennsylvania $11.2B AUM 8.3% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Lasalle Investment Management Securities Baltimore, Maryland $2.65B AUM 6.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AlphaGrep UK's SBRA Position: Q3 2026 in Review

AlphaGrep UK sold out of Sabra Healthcare REIT (SBRA) in Q3 2026, closing a stake of 28,939 shares — an estimated $565K sold.

AlphaGrep UK first reported a position in SBRA in Q2 2026 and held it in 1 quarter. The position peaked at $565K in Q2 2026. 372 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

AlphaGrep UK reported no remaining Sabra Healthcare REIT position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 28,939 Sabra Healthcare REIT shares in Q3 2026, an estimated $565K.
AlphaGrep UK first reported a position in Sabra Healthcare REIT in Q2 2026 and held it in 1 quarter.
AlphaGrep UK's Sabra Healthcare REIT position peaked at $565K in Q2 2026.
372 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.